World Lung Cancer Day: Doctor Explains Why Lung Cancer In Non-Smokers Is On The Rise
According to the World Health Organisation, lung cancer is the leading cause of cancer-related deaths worldwide, with highest mortality rates among both men and women.
WHO has also identified smoking as the leading cause of lung cancer, responsible for approximately 85% of all cases.
Smoking not only affects the smoker but also those exposed to secondhand smoke, which can also contribute to the development of lung cancer in non-smokers. Other than secondhand smoke, many other environmental factors further exacerbate lung cancer risk in non-smokers.
Understanding lung cancer in non-smokers
"No cancer kills more than lung cancer. It is the most common cancer in men worldwide and is placed second when considering the number of new cancer cases in both sexes combined. It accounts for staggering 18% of all cancer deaths each year, while adding 11% to the new cancer burden during the same period. To put it straight, it's one of the cancers which have the poorest outcome," says Dr. Bhuvan Chugh, Principal Consultant - Medical Oncology, Max Hospital, Gurugram.
"The primary risk factor is smoking, which accounts for up to 90% cases of all lung cancers. Smoking increases the relative risk of lung cancer by 10-30-fold, and cessation brings it down by 20-90% and is evident within 5 years of cessation," he adds.
The expert further highlights that a rise in lung cancer cases has been observed in non-smokers over the past decade. "The reasons are a complex interplay between genetic and environmental factors. Environmental smoke exposure remains an important attributable risk in this population. Studies report that females have a 27 percent increased risk if partnered with an individual who smokes," Dr. Chugh states.
The second most important risk factor is air pollution; the International Agency for Research on Cancer (IARC) has classified outdoor pollution and particulate matter (PM) as a Group 1 human carcinogen for lung cancer. For each 10 micrograms of a substance per cubic meter of air increase in PM2.5 and PM10 concentration over the WHO-recommended air quality guidelines, there is an 8% & 9% increase in lung cancer incidence and deaths, respectively.
The difference between smokers' and non-smokers' lung cancer
"There are some vital differences in the lung cancer seen in smokers vs non-smokers. The lung cancer observed in non-smokers is significantly more likely to be driven by one gene, called a driver mutation, and hence is termed as onco-gene addicted lung cancer. This onco-gene addiction provides an opportunity to target the disease by an oral tablet or targeted therapy, both in early as well as advanced stages."
"This has led to improvement in tolerance to the treatment and overall survival. There are more than 10 genes identified that have been termed oncogenes for which targeted therapies are available. The majority of lung cancer patients who are diagnosed undergo genomic sequencing of their tumour for identification of these driver gene mutations before any treatment is given. This precise treatment of lung cancer, leading to improvement in survival, is a marvel of modern medicine," explains Dr. Chugh.
Smoking is a modifiable risk factor for lung cancer. Quitting smoking can greatly reduce the risk of lung cancer and many other serious health conditions.
Disclaimer: This content including advice provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. NDTV does not claim responsibility for this information.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
13 hours ago
- Business Standard
India launches formal rules to fix, streamline drug and device clearances
India has released its first official set of guidelines on how expert panels should review and approve new drugs, medical devices, and biologics, Mint reported. This move is aimed at fixing problems of unclear and inconsistent approvals that have previously slowed down drug launches and weakened the pharmaceutical industry's trust in the system. These new rules, issued by the Central Drugs Standard Control Organisation (CDSCO), are designed to improve how India regulates new medical products. The goal is to make the approval process quicker, more transparent, and predictable, the news report said. The guidelines define how Subject Expert Committees (SECs) should be formed, how experts are chosen, and how they must review applications. These SECs play a key role in advising the Drugs Controller General of India (DCGI) on whether a product should be approved. The overhaul follows recommendations from the World Health Organisation (WHO), which last year conducted a regulatory review of CDSCO and the office of the DCGI, who heads the organisation. The WHO called for stronger transparency and data integrity to align India's system with global standards. Why this is important for India's pharma sector? India's pharmaceutical industry is the world's third-largest by volume and 14th by value. It supplies around 20 per cent of the global generic drug demand and manufactures over 60,000 products across 60 therapy areas. The sector includes generic medicines, vaccines, biologics, over-the-counter drugs, and more. In its review, the WHO had asked Indian authorities to better track low-quality or fake medical products, start a market monitoring programme, and ensure drug advertisements are not misleading. Many of these suggestions are now being followed by the DCGI and those involved in SEC meetings, the news report said. Stricter criteria and structured evaluations Each SEC has eight members — one pharmacologist and seven other experts from research or medical fields. At least four members must be present to make a decision. Earlier, the lack of formal rules often led to delays and confusion in the approval process. Now, SEC members must meet strict criteria, such as having at least 10 published research papers and a 2:1 citation ratio. They are appointed for three years and must follow rules on confidentiality, impartiality, and attendance. Those who miss meetings without good reason can be removed. The new document also says SECs must evaluate drug safety, effectiveness, and risks using strong scientific standards. Decisions like clinical trial waivers must be clearly justified, and discussions must only focus on scientific and regulatory issues — not pricing or business concerns, Mint reported. US hits Indian exports with blanket 25% tariffs The US government has decided to impose a 25 per cent tariff on all Indian exports starting August 7 — without any exemptions. This new order removes earlier tariff breaks given to products like pharmaceuticals, electronics, and energy goods. GTRI founder Ajay Srivastava said this is one of the toughest trade measures by the US against India, news agency PTI reported. India's top export items to the US — like smartphones ($10.9 billion), petroleum products ($4.1 billion), and pharmaceuticals ($9.8 billion) — will be hit hardest. Srivastava said these sectors have high import content and low local value addition, making them vulnerable to the tariff hike. USFDA actions slow down Indian drug approvals Meanwhile, Indian drugmakers are also facing regulatory challenges abroad. In the first quarter of FY25, the US Food and Drug Administration (USFDA) sharply reduced the number of abbreviated new drug application (ANDA) approvals for Indian firms, according to a report by The Times of India. Companies like Cipla, Sun Pharma, Dr Reddy's, Lupin, and Aurobindo Pharma are under increased inspection. Aurobindo's approvals dropped due to issues at its Unit III plant. In May, the company got seven observations from the USFDA at its Bhiwadi facility and earlier three more for its Andhra Pradesh site. Cipla also got six observations for its Goa plant in June. In a filing, the company said it was committed to addressing the concerns in time. A Business Standard report said that the USFDA's Centre for Drug Evaluation and Research recently found that 11 per cent of Indian drug manufacturing facilities had violations, including data integrity issues.
The Hindu
17 hours ago
- The Hindu
Combating the problem of late detection in lung cancer through awareness
World Lung Cancer Day is observed annually on August 1 across the globe. The day was first established in 2012, through the efforts of the Forum of International Respiratory Societies (FIRS) and the International Association for the Study of Lung Cancer (IASLC). This global initiative is mainly aimed at raising awareness and educating people about cancer affecting the lung, it's devastating impact on human life and the importance of preventive measures, early detection, and treatments. It also seeks to combat the stigma often associated with the illness. Also Read: ICMR set to bring in evidence-based norms for prevention, screening, diagnosis, and management of lung cancer A global health challenge Lung cancer remains one of the most common and lethal cancers worldwide, responsible for approximately one in five cancer-related deaths. According to recent health data, over 2 million people are diagnosed each year, and more than 1.8 million lose their lives to the disease. Unfortunately, a significant number of cases are not detected at an early stage, allowing it to progress to an advanced stage with limited and less effective treatment options. This late diagnosis is often due to a lack of public awareness about the risk factors, symptoms and the disease itself. World Lung Cancer Day helps us bridge these gaps in knowledge, underscore the importance of early detection and diagnosis, and create awareness and understanding of the disease. What causes lung cancer? Tobacco smoking remains the leading cause of lung cancer. The risk increases with both the intensity and duration of smoking. In addition to lung cancer, smoking also contributes to stroke, heart disease, other chronic lung diseases and blocks in the blood vessels of the body. Smoking damages the inner lining cells of the air passages to the lungs, leading to changes that develop into cancer over time. However, non smokers are not immune either. Several other risk factors can contribute to the development of lung cancer including second hand smoke exposure also known as passive smoking, radon gas and asbestos exposure, air pollution in cities and industrial areas, occupational hazards (such as exposure to construction, mining or manufacturing industries) and genetic predisposition in people with a family history of lung cancer. Hence environmental health is also a crucial issue in the battle against this disease. Early detection saves lives One of the greatest challenges with lung cancer is its asymptomatic nature in early stages. Often, symptoms do not appear until the disease has already progressed to an advanced stage. If diagnosed at an early stage the chances of successful treatment improve significantly. So what are the symptoms one should be aware of? Symptoms to watch for include: chest pain, a persistent cough, unexplained weight loss, breathing difficulties, tiredness, coughing up blood, and fatigue. CT scans are currently the most effective mode of early detection. Experts emphasise the importance of routine screenings - especially for high-risk individuals, such as long term smokers above the age of 50 years or those with a family history of the disease. Treatment options Treatment of lung cancer is based on the type of cancer, stage or grade of the cancer and overall medical condition of the patient. Treatment options include chemotherapy, radiation therapy, removal of the tumour by surgery, immunotherapy to hike the immune response against cancer and targeted therapy that specifically targets the cancer cells blocking their ability to grow and spread. Steps towards prevention Health professionals stress the importance of quitting smoking, avoiding second-hand smoke, wearing protective gear when working around hazardous materials and advocating for cleaner air and healthier environments. We need stringent anti-tobacco policies to curb its use in the public. Public awareness campaigns, screening programmes and social media initiatives on World Lung Cancer Day have played a crucial role in identifying cases early and improving survival rates Call for support and research On this day, individuals and organisations are encouraged to support lung cancer research and patient care efforts. Donations help fund advancements in early detection, targeted therapy and immunotherapy – treatments that are giving new hope to patients every day. (Dr. Ray George is with the department of cardiovascular and thoracic surgery, Naruvi Hospitals, Vellore. ray.g@
Hans India
21 hours ago
- Hans India
Breastfeeding Week (1 to 7 August): Celebrating nature's first superfood
Breastfeeding is one of the most natural and powerful ways to nourish a newborn. Far beyond being just a means of sustenance, breast milk plays a crucial role in shaping an infant's health, development, and immunity. Packed with essential nutrients and living antibodies, it adapts to a baby's changing needs, offering unparalleled protection in the earliest stages of life. As science continues to uncover the remarkable benefits of breastfeeding, it becomes even clearer why this 'liquid gold' is considered the gold standard of infant nutrition Every year, from August 1st to 7th, the world observes Breastfeeding Week to raise awareness about the importance of breast milk for infants, mothers, and society at large. Organized by the World Alliance for Breastfeeding Action (WABA) and endorsed by the World Health Organization (WHO) and UNICEF, this week serves as a powerful reminder that breastfeeding is not just a personal act—it's a public health imperative. Why Breast Milk Matters Breast milk is more than just food; it's a living, dynamic source of nutrition uniquely tailored for each baby. It contains the perfect balance of proteins, fats, carbohydrates, vitamins, and antibodies that help an infant grow and build immunity. In fact, the first milk produced after childbirth, called colostrum, is often termed 'liquid gold' for its high concentration of protective antibodies and nutrients. 'Breast milk is nature's first vaccine—it not only provides optimal nutrition but also boosts the baby's immune system from day one,' says Dr. Swathi Gogineni, Consultant – Obstetrics & Gynecology, Infertility Specialist & Laparoscopic Surgeon, Apollo Cradle and Children's Hospital, Jubilee Hills, Hyderabad. According to the WHO, exclusive breastfeeding for the first six months of life reduces infant mortality and provides critical protection against diseases such as pneumonia, diarrhea, and even obesity later in life. After six months, continued breastfeeding along with appropriate complementary foods can protect and nourish the child well into the toddler years. Benefits for Babies • Stronger Immunity: Breast milk is packed with antibodies that help babies fight off viruses and bacteria. • Brain Development: Essential fatty acids in breast milk contribute to cognitive development and visual acuity. • Lower Risk of SIDS: Studies show a reduced risk of sudden infant death syndrome in breastfed babies. • Bonding: The act of breastfeeding promotes skin-to-skin contact and emotional bonding between mother and child. Benefits for Mothers • Faster Recovery: Breastfeeding helps the uterus return to its normal size and reduces postpartum bleeding. • Calorie Burn: It naturally helps in burning extra calories, aiding in postpartum weight loss. • Reduced Risk of Diseases: Women who breastfeed have a lower risk of breast and ovarian cancers, Type 2 diabetes, and postpartum depression. • Emotional Connection: It nurtures a deep, hormonal bonding experience that supports maternal mental health. Challenges and the Need for Support While the benefits of breastfeeding are well-documented, not every mother finds it easy. Pain, latching difficulties, lack of information, societal stigma, and returning to work can all be barriers. This is where awareness, education, and support systems are vital. Workplaces need to adopt mother-friendly policies—such as maternity leave, breastfeeding breaks, and hygienic nursing rooms. Hospitals and healthcare providers should promote the Baby-Friendly Hospital Initiative (BFHI) to encourage early initiation and exclusive breastfeeding. Families and communities play a central role, too. Encouraging words, helping hands, and emotional support can make a huge difference in a mother's confidence and commitment to breastfeeding. Spreading the Message This Breastfeeding Awareness Week, let us: • Educate new mothers about the science and benefits of breast milk. • Support lactating mothers at home, in workplaces, and in public spaces. • Normalize breastfeeding through positive messaging in media and community events. • Advocate for policy changes that create breastfeeding-friendly environments. Final Thoughts Breast milk is a natural, sustainable, and cost-effective way to nourish and protect infants. It's the first vaccine, the first food, and the first bond. By spreading awareness and supporting mothers in their breastfeeding journey, we contribute to a healthier generation and a more compassionate society.
